Equities

ReNeuron Group PLC

ReNeuron Group PLC

Actions
  • Price (GBX)27.55
  • Today's Change-0.95 / -3.33%
  • Shares traded32.82k
  • 1 Year change-73.54%
  • Beta--
Data delayed at least 15 minutes, as of Jun 30 2022 16:17 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Thursday, ReNeuron Group PLC (RENE.GB:NXX) closed at 27.55, 8.04% above its 52-week low of 25.50, set on Mar 07, 2022.
52-week range
Today
25.50Mar 07 2022133.50Oct 11 2021
Open28.50
High27.55
Low27.55
Bid--
Offer--
Previous close28.50
Average volume23.11k
Shares outstanding57.06m
Free float39.76m
P/E (TTM)--
Market cap15.84m GBP
EPS (TTM)-0.1854
GBP
Data delayed at least 15 minutes, as of Jun 30 2022 16:17 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.